Comment
. 2010 May 6;362(18):1742-3; author reply 1743-4.
Reevaluating erythropoiesis-stimulating agents
- PMID: 20449880
Item in Clipboard
Comment
Reevaluating erythropoiesis-stimulating agents
N Engl J Med.
.
No abstract available
Comment on
-
Erythropoiesis-stimulating agents--time for a reevaluation.N Engl J Med. 2010 Jan 21;362(3):189-92. doi: 10.1056/NEJMp0912328. Epub 2010 Jan 6. N Engl J Med. 2010. PMID: 20054037 No abstract available.
Similar articles
-
Reevaluating erythropoiesis-stimulating agents.N Engl J Med. 2010 May 6;362(18):1743; author reply 1743-4. N Engl J Med. 2010. PMID: 20449881 No abstract available.
-
Reevaluating erythropoiesis-stimulating agents.N Engl J Med. 2010 May 6;362(18):1742; author reply 1743-4. doi: 10.1056/NEJMc1002263. N Engl J Med. 2010. PMID: 20445190 No abstract available.
-
Response to "effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia".Oncologist. 2005 Oct;10(9):762-3; author reply 764-5. doi: 10.1634/theoncologist.10-9-762. Oncologist. 2005. PMID: 16249359 No abstract available.
-
Novel erythropoiesis-stimulating agents: a new era in anemia management.Clin J Am Soc Nephrol. 2008 Jan;3(1):200-7. doi: 10.2215/CJN.03840907. Epub 2007 Dec 12. Clin J Am Soc Nephrol. 2008. PMID: 18077782 Review.
-
Developments in the therapeutic use of erythropoiesis stimulating agents.Br J Haematol. 2008 May;141(3):287-97. doi: 10.1111/j.1365-2141.2007.06948.x. Br J Haematol. 2008. PMID: 18410567 Review.
Cited by
-
Reports of increased mortality and GH: will this affect current clinical practice?J Clin Endocrinol Metab. 2012 Feb;97(2):380-3. doi: 10.1210/jc.2011-3363. J Clin Endocrinol Metab. 2012. PMID: 22312091 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources